Mitchell P. Kopin 13D and 13G filings for Sunshine Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-23 4:17 pm Purchase | 2025-05-19 | 13G | Sunshine Biopharma, Inc. SBFM | Mitchell P. Kopin | 505,653 9.990% | 505,653 (New Position) | Filing |